whether azithromycin (Zithromax, etc) increases the risk of arrhythmias and cardiovascular death

June 2012

Please see the March 2013 FDA statement concerning the risk QT interval prolongation with Azithromycin

You'll hear new concerns about whether azithromycin (Zithromax, etc) increases the risk of arrhythmias and cardiovascular death.

Erythromycin and clarithromycin can prolong the QT interval and cause fatal arrhythmias (torsades).

Now azithromycin is also associated with a small risk...especially in patients with heart disease.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Diabetes a more "patient-centred" approach for choosing meds to add to metformin for type 2 diabetes
Antibiotics whether azithromycin (Zithromax, etc) increases the risk of arrhythmias and cardiovascular death
Lyme Disease questions about how to prevent or treat Lyme disease
Bowel Preps Too many colonoscopy patients get an inadequate bowel prep
Antithrombotics whether warfarin patients should get HIGHER loading doses and LESS frequent INR monitoring
Statins how to handle statin muscle pain
Antithrombotics new warnings about using Pradax (dabigatran) in patients with kidney impairment or certain heart conditions
Neurology & Pain myths about ketorolac
Neurology & Pain warnings about codeine toxicity, especially in kids
Geriatrics NEW Beers criteria for potentially inappropriate meds in patients 65 and over
Autism questions about meds for autism-related problems